Chief Commercial Officer of $BDSX sells 584 shares in insider transaction

The Chief Commercial Officer of BDSX, Kieran O’Kane, recently sold 584 shares of the company on February 10, 2026, for an estimated $5,889. This transaction, disclosed in a recent SEC filing, represents roughly 6.2% of O’Kane’s holdings in this class of stock, leaving them with 8,885 shares of BDSX stock in their possession. The sale is part of a trend of insider trading activity in BDSX stock, with 20 sales recorded among company insiders in the past 6 months as opposed to only 7 purchases.

Notable insider trading activities in the company include JACK W SCHULER’s seven acquisitions totaling 3,831,255 shares, SCOTT HUTTON’s 4 sales of 8,490 shares, ROBIN HARPER COWIE’s 4 sales of 2,277 shares, KIERAN O’KANE’s 4 sales of 1,383 shares, GARY ANTHONY PESTANO’s 4 sales of 1,303 shares, and CHRIS VAZQUEZ’s 4 sales of 425 shares. These trades collectively reflect the dynamics of BDSX stock transactions among key company figures.

Additionally, hedge funds have made significant moves regarding BDSX stock in recent quarters. For instance, ABERDEEN GROUP PLC added 262,425 shares in Q4 2025, while MONASHEE INVESTMENT MANAGEMENT LLC removed 100,000 shares in Q3 2025. Other institutional investors such as TELEMARK ASSET MANAGEMENT, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, BLACKROCK, INC., GSA CAPITAL PARTNERS LLP, and STATE STREET CORP also made varying adjustments to their BDSX stock positions in the last quarter, reflecting the changing sentiments and strategies of hedge funds towards the company.

Revenue-wise, BDSX reported revenues of $21.8M in Q3 2025, marking a growth of 19.93% compared to the corresponding period in the previous year. This positive trajectory in the company’s financial performance aligns with the insider trading trends and hedge fund activity surrounding BDSX stock, suggesting an overall positive outlook for the company’s operations and valuation moving forward.

Investors interested in tracking BDSX’s financial developments can leverage data and insights provided by platforms like Quiver Quantitative, which offer comprehensive stock tracking tools for monitoring insider transactions, hedge fund activities, and financial metrics related to BDSX stock. It is essential to note that the information presented in this article is not financial advice, and readers are encouraged to consult appropriate disclaimers and seek professional advice before making investment decisions related to BDSX or any other stock.